U.S. Markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
35.97-0.02 (-0.06%)
At close: 4:00PM EDT

35.91 -0.06 (-0.17%)
After hours: 7:11PM EDT

People also watch
Full screen
Previous Close35.99
Bid35.90 x 200
Ask36.07 x 300
Day's Range35.91 - 36.19
52 Week Range29.83 - 36.21
Avg. Volume17,361,603
Market Cap213.93B
PE Ratio (TTM)26.31
EPS (TTM)1.37
Earnings DateOct 31, 2017
Dividend & Yield1.28 (3.61%)
Ex-Dividend Date2017-08-02
1y Target Est37.85
Trade prices are not sourced from all markets
  • Reuters2 hours ago

    Versartis growth hormone drug fails key study, shares sink

    Versartis Inc said its experimental drug for the treatment of growth hormone deficiency in children did not meet the main goal of a late-stage study, sending its shares tanking 85 percent. The drug, somavaratan, ...

  • Business Wire6 hours ago

    National Sickle Cell Disease Poll of African Americans Dispels Long-Held Views

    Pfizer Inc. , the National Newspaper Publishers Association , and scholars from Howard University today announced results from a new national poll designed to deepen understanding and gauge perceptions around sickle cell disease among African Americans.

  • Barrons.com6 hours ago

    [$$] Pfizer's Underappreciated Global Opportunity

    Pfizer (PFE: NYSE) By Morgan Stanley ($35.45, Sept. 20) We are upgrading Pfizer stock from Equal-weight to Overweight and raising our price target from $35 to $39. This is a multiple call. Following underperformance, ...